HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$1.69
Day range
$1.69 - $1.90
Year range
$1.05 - $4.23
Market cap
187.45M USD
Avg Volume
373.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 23.03M | 27.59% |
Operating expense | 49.44M | 0.57% |
Net income | -38.60M | 17.17% |
Net profit margin | -167.59 | 35.08% |
Earnings per share | — | — |
EBITDA | -28.12M | 15.50% |
Effective tax rate | -0.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 194.70M | -16.90% |
Total assets | 272.54M | -11.50% |
Total liabilities | 510.76M | 1.66% |
Total equity | -238.22M | — |
Shares outstanding | 99.18M | — |
Price to book | -0.70 | — |
Return on assets | -23.94% | — |
Return on capital | -31.48% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -38.60M | 17.17% |
Cash from operations | -56.33M | -27.76% |
Cash from investing | -264.00K | 50.28% |
Cash from financing | 271.00K | -23.88% |
Net change in cash | -56.17M | -26.75% |
Free cash flow | -46.27M | -93.87% |
About
Founded
2011
Website
Employees
264
